EGFR INHIBITION TRIGGERS AN ADAPTIVE RESPONSE BY CO-OPTING ANTIVIRAL SIGNALING PATHWAYS… Application EP-4106793-A4 European Patent Office 20 Mar 2024
COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY Application WO-2022223619-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022
COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY Application WO-2022223622-A1 World Intellectual Property Organisation (WIPO) 27 Oct 2022